Table 2.
Comparison of clinical characteristics, anthropometric measurements and body compositions of RA patients with diffebody cell mass (BCM) levels#.
| BCM<median (n = 79) | BCM ≧ median (n = 70) | |
| Age (years) | 60.14 ±11.459 (11.4)21.86±2.360.87±0.0840.10±27.330.75±1.395.36±3.791.26±0.793.97±0.4423.11±3.7519.77±7.058.44±3.2132.22±3.3913.66±1.106.09±2.3954 (68.4) | 52.70±12.59**9 (12.9)26.65±3.13**0.89±0.0725.09±14.85**0.44±0.814.23±1.21*0.87±0.79*4.17±0.51*25.18±4.50*23.17±9.15*9.19±3.8538.98±4.53**15.32±1.45**5.64±3.0541 (62.1) |
| Male (n, %) | ||
| BMI (kg/m2) | ||
| WHR | ||
| ESR (mm/hr) | ||
| CRP (mg/dl) | ||
| DAS28 | ||
| HAQ | ||
| Albumin (mg/dl) | ||
| BCM (kg) | ||
| FM (kg) | ||
| FM index | ||
| SLM | ||
| SLM index | ||
| Prednisolone (mg/day) | ||
| TNF-α inhibitors (n, %) | ||
| DM | 2 (2.5) | 4 (5.7) |
| Hypertension | 33 (41.7) | 21 (30.0) |
| Smoking | 5 (6.3) | 6 (8.6) |
#Data are presented as mean±SD or number (percentage).
RA: rheumatoid arthritis; BCM: body cell mass; BMI: body mass index; WHR: waist-to-hip ratio; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; DAS28: 28-joint disease activity score; HAQ: health assessment questionnaire; FM: fat mass; SLM: skeletal lean mass; TNF-α inhibitors: tumor necrosis factor-α inhibitors;
DM: diabetes mellitus.
The median BCM values were 23.4 and 29.2 in females and males, respectively.
*p<0.05,
**p<0.001, BMC<median vs. BCM≧ median RA patients, p-values. determined by independent sample t-test or chi-squared test.